Physician profile
David Harrison
NPI 1114206968
$1,086.95
in general payments reported to CMS, 2019-2025
21 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $39.66 · 2021: $115 · 2022: $359 · 2023: $36.64 · 2024: $38.40 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $340.98 | 2022-2025 | Stravix Pl, Grafix Pl, Stravix |
| Stryker Corporation | $179.96 | 2022-2025 | 1788, Molli, Spy-Phi System |
| Sanara Medtech INC. | $86.48 | 2021 | |
| Acera Surgical, INC. | $66.57 | 2025 | Restrata Wound Matrix |
| Arthrosurface Incorporated | $43.81 | 2019 | |
| Paratek Pharmaceuticals, INC. | $33.46 | 2022-2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $29.57 | 2019 | |
| Horizon Therapeutics Plc | $28.57 | 2019 | |
| Medtronic Vascular, INC. | $28.53 | 2019-2020 | |
| Paragon 28, INC. | $27.75 | 2022 | |
| Kci USA, INC. | $27.63 | 2020-2021 | |
| Mesh Suture INC | $27.51 | 2025 | |
| Acell, INC. | $27.05 | 2019 | |
| Dilon Technologies, INC. | $26.33 | 2025 | Hemoblast Bellows |
| Nevro Corp. | $20.94 | 2023 | Senza |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20.04 | 2022 | |
| Abbvie INC. | $15.75 | 2024 | |
| Zyla Life Sciences, INC. | $14.55 | 2020 | |
| Amgen INC. | $14.16 | 2025 | Krystexxa |
| Cardiovascular Systems INC. | $13.91 | 2019 | |
| Nabriva Therapeutics, Plc | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.